PHARMACEUTICAL ECONSULTING A/S: Financial statements 2025
CVR: 30815378
Source: annual report 2025, Danish Business Authority
01/10/2024 – 30/09/2025
PHARMACEUTICAL ECONSULTING A/S (CVR 30815378) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 6,113,709 and a net result of DKK -1,066,960 compared with DKK -643,853 the year before. That is an increase of 10.4% compared with the year before. Equity in the 2025 report amounted to DKK 5,152,605. The solvency ratio was 48.6%.
- Gross Profit
- DKK 6,113,709
- Profit/Loss
- DKK -1,066,960
- Equity
- DKK 5,152,605
- Total Assets
- DKK 10,595,150
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 6.1M | -1.1M | 5.2M | 0 |
| 2024 | - | 5.5M | -644K | 6.2M | 8 |
| 2023 | - | 5.6M | -384K | 6.9M | 8 |
| 2022 | - | 6.8M | 780K | 7.2M | 8 |
| 2021 | - | 8.3M | 2.4M | 6.5M | 5 |
Official annual report
How creditworthy is PHARMACEUTICAL ECONSULTING A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PHARMACEUTICAL ECONSULTING A/S has published its annual report for 2024. Gross profit came to DKK 5,538,003, and the net result was DKK -643,853.
About PHARMACEUTICAL ECONSULTING A/S
PHARMACEUTICAL ECONSULTING A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2007. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Steen Otto Rugaard. The board consists of Pernille Laurberg Rugaard (chair), Hanne Laurberg Olesen and Steen Otto Rugaard. The company is owned by RUGAARD HOLDING ApS. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK 6,113,709 and a net result of DKK -1,066,960 compared with DKK -643,853 the year before. Equity in the 2025 report amounted to DKK 5,152,605.